“The rating reflects our assessment of Halifax’s healthy balance of days’ cash on hand, dominant market position, strong non-operating activity and positive demographic trends within its service area and encouraging economic growth,” said S&P credit analyst Patrick Zagar.
The outlook is stable.
S&P has also affirmed the “A-” long-term rating on Halifax Health’s outstanding series 2006A and series 2015 bonds.
More articles on healthcare finance:
Aurora HealthCare taps Strata Decision for financial analytics
Rhode Island hospital scales back services to stem losses|
Lahey Health’s flagship hospital takes financial hit from Epic transition
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
